ERIBULIN MESYLATE
Generic: ERIBULIN MESYLATE
Meitheal Pharmaceuticals Inc.Manufacturer
INTRAVENOUSRoute
ERIBULIN MESYLATEActive Substance
2026-10-19Original Approval
ERIBULIN MESYLATE is FDA application ANDA218930, sponsored by KINDOS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
NEUROPATHY PERIPHERAL
62 reports
2
MYELOSUPPRESSION
57 reports
3
MALIGNANT NEOPLASM PROGRESSION
55 reports
4
PYREXIA
51 reports
5
FATIGUE
42 reports
6
NEUTROPENIA
40 reports
7
OFF LABEL USE
40 reports
8
NAUSEA
36 reports
9
DIARRHOEA
34 reports
10
HEADACHE
30 reports